Back to search

Article

Pan-cancer analysis of DNMT3A as a robust prognostic biomarker to predict the immunotherapy response

2023-07-31

Abstract excerpt

<h4>Background: </h4> DNA methyltransferase 3A (DNMT3A) is essential for de-novo methylation and cell development. Recent studies have shown that dysregulation of methylation regulated by DNMT3A is highly implicated in cancer progression. However, the regulatory roles of DNMT3A in various cancers are not completely clear and need further investigation. Methods The RNA-seq data in The Cancer Genome Atlas (TCGA) an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
587dc48c-fdad-5f0f-b774-63d078597b3e
DOI
10.21203/rs.3.rs-3149495/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pan-cancer analysis of DNMT3A as a robust prognostic biomarker to predict the immunotherapy responseDOI 10.21203/rs.3.rs-3149495/v1
Select a neighboring publication to make it the new centre.